Home Biotechnology Industry News Claremont BioSolutions Awarded $3M Phase II SBIR NIH Grant

Claremont BioSolutions Awarded $3M Phase II SBIR NIH Grant

Claremont BioSolutions announces the award of a $3M Phase II SBIR NIH grant to further develop a sample preparation and detection cartridge for Clostridium difficile.

(PRWeb July 16, 2012)

Read the full story at http://www.prweb.com/releases/2012/7/prweb9696471.htm